Pathophisiology of Sickle Cell Disease and New Drugs for the Treatment

a. agents which reduce or prevent sickle cell dehydration; b. agents which reduce sickle cell-endothelial adhesive events; c. nitric oxide (NO) or NO-related compounds; d. anti-oxidant agents. Correction of the abnormalities ranging from membrane cation transport pathways to red cell-endothelial adh...

Descripción completa

Detalles Bibliográficos
Autor principal: De Franceschi, Lucia
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033152/
https://www.ncbi.nlm.nih.gov/pubmed/21415994
http://dx.doi.org/10.4084/MJHID.2009.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033152/
https://www.ncbi.nlm.nih.gov/pubmed/21415994
http://dx.doi.org/10.4084/MJHID.2009.024

Ejemplares similares